Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1W62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,266
Award facts
- Contract value 100% obligated
- $12,266.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,266.07 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 22, 2026, for the supply of Gardasil 9 Syringe 0.5ML, a human papillomavirus vaccine. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, was awarded on a non-set-aside, competitive basis. The contractor will perform the work at its corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare systems.
This delivery order is issued under a larger Indefinite Delivery Contract vehicle—the DLA Troop Support Medical Pharmaceutical Prime Vendor program (valued at up to $999,999,999.00 through December 2026)—which enables comprehensive pharmaceutical support across military healthcare programs worldwide. The IDC encompasses a broad range of medical commodities including specialty medications, generic and brand-name drugs, vaccines, and medical supplies across multiple therapeutic domains. This contract awards delivery demonstrates AmerisourceBergen's role as a critical pharmaceutical supplier to the Department of Defense and military healthcare systems, supporting the delivery of vaccines and essential medical products required by defense medical treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F1W62?
SPE2DR26F1W62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F1W62 worth?
The government has obligated $12,266 on SPE2DR26F1W62.
Is contract SPE2DR26F1W62 an order under another contract?
Yes. SPE2DR26F1W62 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1W62 competed?
The extent of competition for SPE2DR26F1W62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award